Mazor Robotics (NASDAQ:MZOR) Upgraded to “Strong-Buy” by BidaskClub

BidaskClub upgraded shares of Mazor Robotics (NASDAQ:MZOR) from a buy rating to a strong-buy rating in a report published on Wednesday, March 14th.

Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Mazor Robotics from a hold rating to a buy rating and set a $74.00 price target for the company in a research report on Friday, February 2nd. Vetr upgraded shares of Mazor Robotics from a hold rating to a buy rating and set a $66.27 target price on the stock in a report on Thursday, March 1st. Finally, Needham & Company LLC restated a hold rating on shares of Mazor Robotics in a report on Wednesday, February 14th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $49.21.

How to Become a New Pot Stock Millionaire

Shares of MZOR traded down $1.90 on Wednesday, hitting $58.18. 272,977 shares of the stock traded hands, compared to its average volume of 580,686. The company has a market capitalization of $1,533.36, a P/E ratio of -116.36 and a beta of 1.20. Mazor Robotics has a one year low of $27.65 and a one year high of $76.56.

Mazor Robotics (NASDAQ:MZOR) last announced its quarterly earnings results on Wednesday, February 14th. The medical instruments supplier reported $0.02 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.09. The company had revenue of $19.15 million during the quarter, compared to the consensus estimate of $19.00 million. Mazor Robotics had a negative net margin of 19.08% and a negative return on equity of 14.03%. The firm’s quarterly revenue was up 36.4% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.07) earnings per share. equities analysts predict that Mazor Robotics will post 0.06 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of MZOR. Ark Investment Management LLC boosted its holdings in Mazor Robotics by 104.9% in the second quarter. Ark Investment Management LLC now owns 21,410 shares of the medical instruments supplier’s stock worth $740,000 after purchasing an additional 10,962 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Mazor Robotics by 8.1% in the second quarter. Dimensional Fund Advisors LP now owns 8,570 shares of the medical instruments supplier’s stock worth $296,000 after purchasing an additional 641 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its holdings in Mazor Robotics by 3.0% in the third quarter. Gilder Gagnon Howe & Co. LLC now owns 238,647 shares of the medical instruments supplier’s stock worth $11,782,000 after purchasing an additional 6,905 shares during the last quarter. Advisor Group Inc. boosted its holdings in Mazor Robotics by 365.8% in the third quarter. Advisor Group Inc. now owns 2,795 shares of the medical instruments supplier’s stock worth $138,000 after purchasing an additional 2,195 shares during the last quarter. Finally, Sigma Planning Corp purchased a new position in shares of Mazor Robotics during the 3rd quarter worth $443,000. Institutional investors own 24.07% of the company’s stock.

WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/07/mazor-robotics-mzor-rating-increased-to-strong-buy-at-bidaskclub.html.

Mazor Robotics Company Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness.

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply